Opens in a new tab
Monday, 16 November 2026
EVIDENCE. INTERPRETED.
Policy & Acquisitions

Mergers & Acquisitions

Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.

Advertisement · Remove ads
970 × 90

Latest in Mergers & Acquisitions

214 stories · every one Fact-Checked
Professionals sealing a deal with a handshake across a conference table during a business meeting.Mergers & AcquisitionsChiesi Seals a Strategic Win with $1.9B KalVista AcquisitionChiesi Group will acquire KalVista Pharmaceuticals in a $1.9 billion deal, adding the first oral on-demand treatment for Hereditary Angioedema and strengthening its rare disease portfolio.30 Apr 2026 · 3 min read
Fact-Checked
Teva_Logo_RGBMergers & AcquisitionsTeva to Acquire Emalex and Add Tourette Drug EcopipamTeva Pharmaceuticals will acquire Emalex Biosciences and its lead asset ecopipam, a late-stage therapy for pediatric Tourette syndrome that met its Phase 3 primary endpoint.29 Apr 2026 · 3 min read
Fact-Checked
5478Mergers & AcquisitionsProfluent and Eli Lilly Chase the ‘Holy Grail’ of DNA EditingProfluent has entered a multi-program collaboration with Eli Lilly to develop AI-designed recombinases for site-specific DNA editing.29 Apr 2026 · 2 min read
Fact-Checked
A blue-gloved hand holds a card with 'Find a Cure' message, symbolizing cancer awareness.Mergers & AcquisitionsBioMarin Bolsters Its Rare Disease Portfolio Through Amicus AcquisitionBioMarin has finalized its $4.8 billion acquisition of Amicus Therapeutics, strengthening its rare disease portfolio with approved therapies for Fabry and Pompe diseases and a late-stage kidney disease…27 Apr 2026 · 2 min read
Fact-Checked
Close-up of two business professionals shaking hands, symbolizing partnership and collaboration.Mergers & AcquisitionsEli Lilly Bets Big on Next-Gen JAK2 Science with Ajax Therapeutics DealEli Lilly and Company will acquire Ajax Therapeutics in a deal worth up to $2.3 billion, centered on AJ1-11095, a novel Type II JAK2 inhibitor in early clinical…27 Apr 2026 · 3 min read
Fact-Checked
Gemini_Generated_Image_nji3f1nji3f1nji3Mergers & AcquisitionsSun Pharma Acquires Organon in $11.75 Billion DealSun Pharma $11.75 billion acquisition of Organon strengthens its position in women’s health and biosimilars while expanding global scale and portfolio diversification.27 Apr 2026 · 2 min read
Fact-Checked
A healthcare worker prepares a vaccine outdoors in Ovejas, Colombia, emphasizing COVID-19 safety and healthcare provision.Mergers & AcquisitionsSerum Institute Joins VaxThera to Expand Vaccine Access in ColombiaVaxThera and Serum Institute of India form a strategic collaboration to expand vaccine production in Colombia, aiming to improve access, reduce import reliance, and enhance regional health resilience.25 Apr 2026 · 2 min read
Fact-Checked
Colorful paper cutouts of diverse hands surrounding a small paper Earth, symbolizing unity.Mergers & AcquisitionsSerum Institute of India Teams with Oxford to Reinforce the Fight Against Malaria with R78COxford and Serum Institute of India expand their partnership with a new licence for the R78C malaria vaccine candidate, aiming to improve efficacy through a multi-stage approach and…25 Apr 2026 · 2 min read
Fact-Checked
AbbVie US Headquarters Angle 3Mergers & AcquisitionsAbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinEAbbVie reported an FDA Complete Response Letter for trenibotulinumtoxinE, focused on manufacturing details, while clinical data supporting safety and efficacy remains intact.24 Apr 2026 · 2 min read
Fact-Checked
Eagle catching fish from the water surface, showcasing nature's raw hunting skill.Mergers & AcquisitionsApotex to Acquire Cumberland’s Branded Drug Portfolio in $100M DealCumberland Pharmaceuticals has agreed to sell its branded commercial portfolio to Apotex for $100 million.24 Apr 2026 · 2 min read
Fact-Checked
Close-up of Scrabble tiles spelling 'deal' with a handshake in the background.Mergers & AcquisitionsAmneal Bets Big on Biosimilars with Kashiv AcquisitionAmneal Pharmaceuticals, Inc. has agreed to acquire Kashiv BioSciences, LLC in a transaction combining cash, equity, and milestone-based payments.23 Apr 2026 · 3 min read
Fact-Checked
Close-up of a robot hand and silver-gloved hand touching, symbolizing human-robot connection.Mergers & AcquisitionsMerck Builds AI-Enabled Enterprise with Support from Google CloudMerck has entered a multi-year collaboration with Google Cloud to integrate advanced AI technologies, including Gemini Enterprise, across its operations to improve efficiency, accelerate drug development, and enhance…22 Apr 2026 · 2 min read
Fact-Checked
Page 14 of 18